(Q37100702)

18 August 2017

1 reference

title

Update in pulmonary arterial hypertension 2007. (English)

1 reference

18 August 2017

main subject

arterial hypertension

0 references

1

Marc Humbert

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

American Journal of Respiratory and Critical Care Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

177

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

574-579

1 reference

Update in pulmonary hypertension 2005.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

An epidemiological study of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

A USA-based registry for pulmonary arterial hypertension: 1982-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary diseases and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Severe pulmonary hypertension and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Genes and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pathogenesis of pulmonary arterial hypertension: the need for multiple hits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Inflammation in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Results of European post-marketing surveillance of bosentan in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Long term imatinib treatment in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Congestive heart failure is a rare event in patients receiving imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-029UP

10.1164/RCCM.200801-029UP

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference